How can regulatory pathways be adapted to facilitate the development and approval of new antimicrobial agents, especially for drug-resistant pathogens like Pseudomonas aeruginosa?

The typing database contains nomenclature - allele definitions that provide an identifier for every unique allele sequence, and MLST profiles that index each ... Pseudomonas aeruginosa is commonly found transiently on the skin, especially in the axillary and anogenital regions, and readily colonises ulcers and moist ... abstract. The wbp gene cluster, encoding the B-band lipopolysaccharide O antigen of Pseudomonas aeruginosa serotype O5 strain PAO1, was previously shown to ... Pseudomonas infection ... Pseudomonas is a germ found in the environment. It can occur in moist areas such as sinks or baths. It rarely causes illness outside a ... Pseudomonas aeruginosa is a free-living, aerobic and motile Gram-negative rod bacterium. It is the cause of several disorders in animals and human. Pseudomonas aeruginosa (P. aeruginosa) is the most common Gram-negative rod infection, especially in severely sick and vulnerable individuals. Treatment ... Dec 16, 2024 ... ... infection due to P aeruginosa. Secondary outcomes included all ... Pseudomonas aeruginosa infection. Infect Drug Resist. 2022; 15:655 ... Pseudomonas aeruginosa are strains of bacteria that are widely found in the environment. Pseudomonas is a major cause of lung infections in people with ... OHSU-TD-1160: Fundamental study of the initial bacterial attachment of Pseudomonas aeruginosa, Pseudomonas putida and Escherichia coli. Ohio Sea Grant is a ... In this paper, we rigorously explore the role of two major bacterial adhesins, type IV pili (Tfp) and flagella, in bacterial adherence to distinct host ...